###begin article-title 0
Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 841 846 <span type="species:ncbi:9606">human</span>
###xml 899 904 <span type="species:ncbi:10090">mouse</span>
###xml 923 928 <span type="species:ncbi:9606">human</span>
###xml 933 938 <span type="species:ncbi:10090">mouse</span>
Neuroinflammation has been implicated in various brain pathologies characterized by hypoxia and ischemia. Astroglia play an important role in the initiation and propagation of hypoxia/ischemia-induced inflammation by secreting inflammatory chemokines that attract neutrophils and monocytes into the brain. However, triggers of chemokine up-regulation by hypoxia/ischemia in these cells are poorly understood. Hypoxia-inducible factor-1 (HIF-1) is a dimeric transcriptional factor consisting of HIF-1alpha and HIF-1beta subunits. HIF-1 binds to HIF-1-binding sites in the target genes and activates their transcription. We have recently shown that hypoxia-induced expression of IL-1beta in astrocytes is mediated by HIF-1alpha. In this study, we demonstrate the role of HIF-1alpha in hypoxia-induced up-regulation of inflammatory chemokines, human monocyte chemoattractant protein-1 (MCP-1/CCL2) and mouse MCP-5 (Ccl12), in human and mouse astrocytes, respectively.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 76 80 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 94 98 86 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 157 159 148 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Primary fetal human astrocytes or mouse astrocytes generated from HIF-1alpha+/+ and HIF-1alpha+/- mice were subjected to hypoxia (<2% oxygen) or 125 muM CoCl2 for 4 h and 6 h, respectively. The expression of HIF-1alpha, MCP-1 and MCP-5 was determined by semi-quantitative RT-PCR, western blot or ELISA. The interaction of HIF-1alpha with a HIF-1-binding DNA sequence was examined by EMSA and supershift assay. HIF-1-binding sequence in the promoter of MCP-1 gene was cloned and transcriptional activation of MCP-1 by HIF-1alpha was analyzed by reporter gene assay.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 133 134 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 211 215 199 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 330 332 314 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 345 349 325 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 363 367 339 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 454 456 426 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 597 599 565 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 195 200 <span type="species:ncbi:10090">Mouse</span>
###xml 509 514 <span type="species:ncbi:9606">human</span>
Sequence analyses identified HIF-1-binding sites in the promoters of MCP-1 and MCP-5 genes. Both hypoxia and HIF-1alpha inducer, CoCl2, strongly up-regulated HIF-1alpha expression in astrocytes. Mouse HIF-1alpha+/- astrocytes had lower basal levels of HIF-1alpha and MCP-5 expression. The up-regulation of MCP-5 by hypoxia or CoCl2 in HIF-1alpha+/+ and HIF-1alpha+/- astrocytes was correlated with the levels of HIF-1alpha in cells. Both hypoxia and CoCl2 also up-regulated HIF-1alpha and MCP-1 expression in human astrocytes. EMSA assay demonstrated that HIF-1 activated by either hypoxia or CoCl2 binds to wild-type HIF-1-binding DNA sequence, but not the mutant sequence. Furthermore, reporter gene assay demonstrated that hypoxia markedly activated MCP-1 transcription but not the mutated MCP-1 promoter in transfected astrocytes.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
These findings suggest that both MCP-1 and MCP-5 are HIF-1 target genes and that HIF-1alpha is involved in transcriptional induction of these two chemokines in astrocytes by hypoxia.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 447 448 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 449 451 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 637 638 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 639 640 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 901 903 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1052 1054 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1055 1057 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1310 1312 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1313 1315 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1400 1402 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1403 1405 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1547 1549 1506 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1550 1552 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1553 1555 1512 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1685 1686 1640 1641 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1721 1723 1676 1678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1724 1726 1679 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1751 1753 1706 1708 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1784 1786 1739 1741 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1916 1918 1867 1869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1919 1921 1870 1872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1994 1996 1941 1943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1997 1999 1944 1946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 2103 2105 2050 2052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 2177 2179 2120 2122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 2180 2182 2123 2125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 2183 2185 2126 2128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 2682 2684 2614 2616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 2685 2687 2617 2619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 2688 2690 2620 2622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 2691 2693 2623 2625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 2857 2859 2789 2791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 2985 2987 2917 2919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 2990 2999 2922 2931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 3015 3017 2947 2949 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 3168 3170 3096 3098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 3171 3173 3099 3101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 3174 3176 3102 3104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 3200 3201 3128 3129 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 3244 3253 3172 3181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 3254 3256 3182 3184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 3262 3270 3190 3198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 3271 3273 3199 3201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 3323 3328 <span type="species:ncbi:9606">human</span>
###xml 3329 3337 <span type="species:ncbi:9606">patients</span>
Ischemic brain damage, including that caused by stroke and trauma, elicits inflammation in the injured areas [1-3]. A number of inflammatory mediators are expressed in the brain in response to ischemia and hypoxia [1-4]. Hypoxia or ischemia stimulates the expression of inflammatory cytokines (IL-1beta, TNF-alpha), chemokines (IL-8, MCP-1/CCL2) and adhesion molecules (ICAM-1) in the brain and in cultured astrocytes and brain endothelial cells [5-10]. These inflammatory mediators play a critical role not only in the initiation and propagation of ischemica/hypoxia-evoked neuroinflammation but also in the resolution of brain damage [1-4]. However, triggers of inflammatory chemokine up-regulation by hypoxia/ischemia in these cells are poorly understood. We have recently shown that hypoxia-stimulated IL-1beta expression in astrocytes is mediated by hypoxia-inducible factor-1alpha (HIF-1alpha) [11]. Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that plays a central role in cellular and systemic homeostatic responses to hypoxia [12-14]. HIF-1 is a heterodimeric protein complex consisting of two subunits, the redox-sensitive HIF-1alpha (120-130 kD), which is unique to HIF-1, and the constitutively expressed HIF-1beta (91-94 kD), a common partner for many other transcription factors [12-14]. Both subunits are necessary for DNA binding and activation of HIF-1 target genes [15,16]. Several HIF-1alpha isoforms have been found, including HIF-2alpha and HIF-3alpha, both of which have significant homologies to HIF-1alpha [13,14,17]. Although these HIF-1 isoforms may also contribute to the response to hypoxia, HIF-1alpha is considered the major regulator of O2-tension sensitive genes in cells [12,13]. Decrease in cellular O2 tension or the presence of CoCl2 or desferroxamine leads to elevation of HIF-1alpha expression, whereas carbon monoxide and nitric oxide inhibit HIF-1 activation [18-20]. HIF-1alpha is cytosolic and degraded by ubiquitin-proteasome pathway [21,22] via binding of von Hippel-Lindau tumor suppressor protein to the oxygen-dependent degradation domain [23]. Hypoxia induces HIF-1alpha expression in tissues and cultured cells [12,13,24]. The length of hypoxic stress determines HIF-1alpha half-life upon reoxygenation. During hypoxia, HIF-1alpha is stabilized and dimerized with HIF-1beta, and the complex is translocated into nucleus where it binds to hypoxia-responsive elements in the promoters or enhancers of the target genes, such as the genes encoding erythropoetin (EPO), glucose transporters, glycolytic enzymes, heme oxygenase-1, inducible nitric oxide synthase, transferin, and vascular endothelial growth factor (VEGF) [12-14,25,26]. The consensus DNA sequence for HIF-1 binding in the hypoxia-response element is 5'-[A/G]CGTG-3' flanked with or without a second consensus site 5'-[A/C]ACAG-3' [12]. Mutations of the consensus sequences result in loss of HIF-1 binding and transcriptional response of the genes to hypoxia [12]. In vitro exposure to CoCl2 or iron chelator deferoxamine under normoxic conditions produces a hypoxia-mimetic effect with up-regulation of HIF-1alpha and target gene expression [12-14,26]. Cobalt chloride (CoCl2) increases erythropoetin (EPO) production in vitro [27] and in vivo [28] under normoxic conditions and was once given to human patients to treat anemia.
###end p 11
###begin p 12
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 187 196 187 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 549 550 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 307 312 <span type="species:ncbi:9606">human</span>
###xml 555 560 <span type="species:ncbi:10090">Mouse</span>
###xml 746 751 <span type="species:ncbi:9606">human</span>
###xml 923 928 <span type="species:ncbi:9606">human</span>
###xml 933 938 <span type="species:ncbi:10090">mouse</span>
Astroglial cells are the most abundant cells in the brain and serve as an important source of inflammatory mediators during the course of neuroinflammation [1-3]. Astrocytes subjected to in vitro ischemia/hypoxia produce a large amount of chemoattractant MCP-1 which is 30-time higher than that secreted by human brain endothelial cells subjected to the same treatment [6]. MCP-1 is a potent chemokine and directs the transmigration of blood-borne monocytes/macrophages across the blood-brain barrier (BBB) into the inflammatory sites in the brain [1-3]. Mouse monocyte chemoattractant protein-5 (MCP-5), known as chemokine (C-C motif) ligand 12 (Ccl12) or small inducible cytokine A12 (Scya12), is also a potent monocyte chemokine homologous to human MCP-1 with 66% amino acid identity [29]. This study shows that HIF-1alpha is involved in transcriptional activation of MCP-1 and MCP-5 expression stimulated by hypoxia in human and mouse astrocytes, respectively.
###end p 12
###begin title 13
Materials and methods
###end title 13
###begin title 14
Animal use and genotyping
###end title 14
###begin p 15
###xml 149 153 145 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 307 309 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 399 403 391 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 417 421 405 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 447 451 431 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 465 469 445 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 537 539 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 552 556 528 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 592 594 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 633 636 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 657 660 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1343 1344 1305 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1347 1349 1309 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1381 1383 1343 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1529 1532 1487 1490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1619 1622 1573 1576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 1513 1517 <span type="species:ncbi:10090">mice</span>
###xml 1603 1607 <span type="species:ncbi:10090">mice</span>
All procedures involving animals were approved by the Animal Care and Use Committee of the NRC-Institute for Biological Science (NRC-IBS). HIF-1alpha+/- heterozygous mice were obtained from the Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Belgium [30] and bred in the Animal Facility at the NRC-IBS. Offspring from mating between HIF-1alpha+/+ and HIF-1alpha+/- mice or between HIF-1alpha+/- and HIF-1alpha+/- mice was genotyped by polymerase chain reaction (PCR) as described [30]. HIF-1alpha-/- is lethal in embryonic development [30]. To identify heterozygous (HIF-1alpha+/-) or wild (HIF-1alpha+/+) littermates, genomic DNA samples of the offspring were analyzed at 7 days of age. In brief, tissues obtained by tail clipping were digested at 55degreesC for 18 h in a lysis buffer containing 1 mg/ml proteinase K, 0.5% lauryl sulfate (SDS), 100 mM NaCl, 50 mM Tris-HCl (pH8.0), and 7.5 mM EDTA (pH 8.0) (Sigma, Oakville, ON). Genomic DNA was extracted using phenol-isoamyl alcohol and precipitated with isopropanol (Invitrogen, Burlington, ON). DNA pellets were resuspended in TE buffer containing 10 mM Tris-HCl (pH 8.0) and 1 mM EDTA (pH 8.0). Genomic DNA was amplified in a single tube for 35 PCR cycles using a set of three specific primers (HIF700, HIF960, and NEO187) (Table 1) [30]. PCR, performed as described [11], generated a 380 bp DNA fragment (HIF960 and NEO187 primers) and a 230 bp fragment (HIF700 and HIF960 primers) for heterozygous mice (HIF-1alpha+/-) and only a 230 bp fragment (HIF700 and HIF960 primers) for wild-type mice (HIF-1alpha+/+).
###end p 15
###begin p 16
PCR primer sequences
###end p 16
###begin title 17
Cell cultures
###end title 17
###begin p 18
###xml 73 77 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 91 95 83 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 149 151 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 803 804 794 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1133 1134 1117 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1135 1136 1119 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1137 1139 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1228 1232 1208 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1246 1250 1222 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1399 1403 1371 1375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1417 1421 1385 1389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1441 1443 1409 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 163 168 <span type="species:ncbi:10090">mouse</span>
###xml 945 951 <span type="species:ncbi:9913">bovine</span>
Primary mouse astrocyte cultures were generated from 7-day old HIF-1alpha+/+ and HIF-1alpha+/- mice using a modified technique previously described [31]. Briefly, mouse brains were dissected under sterile conditions and meningeal tissues were removed. The minced brain tissues were mechanically dissociated by passing through needles of increasing gauge (18, 23, and 25) and subsequent 15-minute exposure to dispase (3 mg/ml). The resulting cell suspensions were passed through a sterile nylon mesh (Nitex) sieve (32 mum pore size) into Dulbecco's modified Eagle's medium (D-MEM) (Invitrogen, Burlington, ON). After centrifugation at 1200 rpm for 10 minutes at room temperature, the cells were seeded into culture dishes coated with sterile poly-lysine. The cells were cultured in an atmosphere of 5% CO2/95% air at 37degreesC in D-MEM containing 4.5 g/L glucose, 2 mM glutamine, 25 mug/ml gentamycin (Invitrogen, Burlington, ON), and 10% fetal bovine serum (FBS, HyClone, Logan, UT, U.S.A.). The purity of the astrocyte cultures was determined by staining with the specific astrocyte marker, glial fibrillary acidic protein (GFAP) [6-8,11]. More 95% of the cells in cultures were GFAP-positive (data not shown). Both HIF-1alpha+/+ and HIF-1alpha+/- astrocyte cultures showed similar morphology and GFAP-staining. Passages 3-6 of the cultures were used at 80%-90% confluence. Immortalized HIF-1alpha+/+ and HIF-1alpha+/- astrocyte cultures [11] were used in some of the experiments (western blot, EMSA and supershift assays). The morphology and immunochemical characteristics (100% immuno-positive for GFAP), and culture conditions used for immortalized cells were the same for the primary astrocytes, except that passages 11-14 were used in the western blot, EMSA and supershift assays.
###end p 18
###begin p 19
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 6 11 <span type="species:ncbi:9606">human</span>
###xml 189 194 <span type="species:ncbi:9606">human</span>
###xml 429 434 <span type="species:ncbi:10090">mouse</span>
Fetal human (10-18 weeks of gestation) astrocyte (FHAs) cultures were generously provided by Dr. J. Antel at the Montreal Neurological Institute, Montreal, Quebec. The use of primary fetal human astrocytes was approved by the Research Ethics Board of National Research Council of Canada. The FHAs cultures were prepared using the same protocol as described above [31] and grown using the same media and culture conditions as the mouse astrocytes [8,11]. More than 95% of the cells in FHAs cultures were stained positive for GFAP (data not shown).
###end p 19
###begin title 20
In vitro hypoxia
###end title 20
###begin p 21
###xml 22 31 22 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 398 400 398 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 514 515 507 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 773 774 752 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 338 343 <span type="species:ncbi:10090">mouse</span>
###xml 813 818 <span type="species:ncbi:9606">human</span>
###xml 865 870 <span type="species:ncbi:10090">mouse</span>
Cells were exposed to in vitro hypoxia in an anaerobic chamber (Anaerobic System Model 1024, Forma Scientific, Canada) equipped with a humidified, temperature controlled incubator as described [7,8]. The cells were washed once in Hank's balanced salt solution (HBSS) (Sigma, Oakville, ON) and serum-free D-MEM was added to the cells. For mouse astrocytes, hypoxic incubation was performed at < 2% O2 in the anaerobic chamber at 37degreesC for 6 h. Alternatively, cells were exposed to 125 muM cobalt chloride (CoCl2) (Sigma) for 6 h at 37degreesC. Media and cells were harvested for MCP-5 ELISA assay, RT-PCR detection of HIF-1alpha and MCP-5 mRNA expression, and western blot analysis of HIF-1alpha, respectively. For FHAs, both hypoxic treatment and cobalt chloride (CoCl2) exposure were instead for 4 h, since human astrocytes are more sensitive to hypoxia than mouse astrocytes. The media and cells were harvested for MCP-1 ELISA, RT-PCR and EMSA, respectively.
###end p 21
###begin title 22
Semi-quantitative RT-PCR
###end title 22
###begin p 23
###xml 217 218 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 302 303 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 434 435 425 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 904 905 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1118 1123 <span type="species:ncbi:9606">human</span>
###xml 1128 1133 <span type="species:ncbi:10090">mouse</span>
###xml 1168 1173 <span type="species:ncbi:10090">mouse</span>
###xml 1203 1208 <span type="species:ncbi:9606">human</span>
###xml 1256 1261 <span type="species:ncbi:9606">human</span>
###xml 1266 1271 <span type="species:ncbi:10090">mouse</span>
Total RNA was isolated from astrocytes using Trizol (Invitrogen) according to the manufacturer's protocol. Synthesis of first-stand cDNA was performed by reverse transcription (RT) for 1 h at 42degreesC as described [7]. PCR primers were designed according to published sequences in the GenBank (Table 1). PCR amplifications were carried out in a final volume of 25 mul containing 2.5 mul of 10x reaction buffer, 1.5 mul of 25 mM MgCl2, 0.5 mul of 10 mM dNTP, 0.25 mul of Taq DNA polymerase (Promega, Madison, WI) (5 unit/mul), 1.0 mul of each 10 muM primer, and 2 mul cDNA. All amplifications were done using a heating for 5 min at 94degreesC, denaturation step at 94degreesC for 60 sec, annealing step at 60degreesC for 60 sec, and polymerization step at 72degreesC for 60 sec, and were carried out for 35 cycles. All the genes were linearly amplified during the 35 PCR cycles determined as described [7] (data not shown). The resulting PCR was electrophoresed on 1.2% agarose gels in Tris-borate buffer containing 0.5 mug/ml ethidium bromide (Sigma), and then photographed. The PCR generated a 504 DNA fragment for human and mouse HIF-1alpha, a 312 bp fragment for mouse MCP-5, a 257 bp fragment for human MCP-1, and a 421 bp fragment for beta-actin of human and mouse. Signal intensity of the products was quantified by calculating the integrated volume of the band with a Computing Laser Densitometer (Model 300A, Molecular Dynamic, CA) and analyzed using ImageQuaNT, version 4.1 software (Molecular Dynamics, CA). Obtained values were expressed as percentages of the internal controls.
###end p 23
###begin title 24
ELISA
###end title 24
###begin p 25
The levels of immunoreactive MCP-1 and MCP-5 released from astrocytes into culture media were measured by the enzyme-linked immunosorbent assays (ELISA), using commercial MCP-1 (ID Labs Inc., London, ON) and MCP-5 kits (Amersham Biosciences, Montreal, PQ), respectively. Prior to ELISA assays, aliquots of culture media collected and stored at -80degreesC were thawed and centrifuged at 14,000 rpm for 5 min at 4degreesC before the assays to remove cell debris. The assays were performed as instructed by the manufacturers.
###end p 25
###begin title 26
Western blot
###end title 26
###begin p 27
###xml 16 20 12 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 34 38 26 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 88 90 79 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 167 169 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 268 270 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 648 650 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 875 876 856 857 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 359 365 <span type="species:ncbi:9986">rabbit</span>
###xml 479 483 <span type="species:ncbi:9925">goat</span>
###xml 489 495 <span type="species:ncbi:9986">rabbit</span>
Mouse HIF-1alpha+/+ and HIF-1alpha+/- astrocytes were exposed to hypoxia or 125 muM CoCl2 for 6 h. Nuclear extracts were prepared from the treated-cells as described [11]. Equal amounts of nuclear protein (20 mug) from each sample were resolved on a 10% SDS-PAGE gel [11]. After the proteins were resolved on the gel and blotted to nitrocellulose membrane, a rabbit anti-HIF-1alpha antibody (CAT# NB 100-654, Novus Biologicals Inc., Littleton, CO) and a secondary HRP-conjugated goat anti-rabbit IgG antibody (CAT# sc-2004, Santa Cruz Biotech Inc., Santa Cruz, CA) were used sequentially at 1:1000 and 1:3000 dilutions, respectively, as described [11]. ECL Plus reagents (Amersham Biosciences Inc) were then applied to the membranes and the membranes were exposed to X-ray film for 30 min to detect the levels of HIF-1alpha protein in cells exposed to hypoxia or 125 muM CoCl2.
###end p 27
###begin title 28
Electrophoretic mobility shift assay (EMSA) and supershift assay
###end title 28
###begin p 29
###xml 89 91 88 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 150 151 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 152 154 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 379 384 378 383 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ACGTG</underline>
###xml 379 384 378 383 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>ACGTG</underline></bold>
###xml 438 443 437 442 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AAAAG</underline>
###xml 438 443 437 442 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>AAAAG</underline></bold>
###xml 463 465 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 466 468 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 572 574 567 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1251 1252 1238 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
###xml 1046 1052 <span type="species:ncbi:9986">rabbit</span>
Nuclear extracts were prepared from mouse astrocytes treated with hypoxia or 125 muM CoCl2 for 6 h using a modified protocol as described previously [8,11]. The protein concentrations of the nuclear extracts were determined using the Bradford assay (BioRad Laboratories, Hercules, CA). For the EMSA, a typical double-stranded consensus oligonucleotide for HIF-1 binding (5'-TCTGTACGTGACCACACTCACCTC-3') and a mutant DNA sequence (5'-TCTGTAAAAGACCACACTCACCTC-3') [15,16] were purchased from Santa Cruz Biotech Inc (CAT # sc-2625, Santa Cruz, CA) and end-labeled with gamma[32P]-ATP (Mandel/NEN Life Science, Guelph, ON). Nuclear proteins (5 mug) were incubated with 2 mug poly-d [I-C] (Amersham Biosciences, Montreal, Quebec) in DNA binding buffer containing 20 mM HEPES (pH 7.9), 0.2 mM EDTA, 0.2 mM EGTA, 100 mM KCl, 5% glycerol, and 2 mM DTT (Sigma) for 10 min at room temperature. Labeled probe (2 ng) was then added to the reaction mixture and incubated for 30 min at room temperature in a final volume of 20 mul. For supershift assay, 4 mug rabbit anti-HIF-1alpha antibody (CAT# NB 100-654, Novus Biologicals Inc., Littleton, CO) was added to the reactions. DNA-protein complexes were separated from unbound DNA on native 5% polyacrylamide gels [8]. The gels were dried and exposed to an X-ray film.
###end p 29
###begin title 30
Luciferase reporter gene assay
###end title 30
###begin p 31
###xml 112 117 112 117 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ACGTG</underline>
###xml 112 117 112 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>ACGTG</underline></bold>
###xml 122 127 122 127 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CACAG</underline>
###xml 122 127 122 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>CACAG</underline></bold>
###xml 194 199 194 199 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CACAG</underline>
###xml 194 199 194 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>CACAG</underline></bold>
###xml 313 319 313 319 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ggtacc</underline>
###xml 329 334 329 334 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ACGTG</underline>
###xml 329 334 329 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>ACGTG</underline></bold>
###xml 369 375 369 375 <underline xmlns:xlink="http://www.w3.org/1999/xlink">agatct</underline>
###xml 384 389 384 389 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CTGTG</underline>
###xml 384 389 384 389 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>CTGTG</underline></bold>
###xml 924 929 924 929 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ATTTG</underline>
###xml 924 929 924 929 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>ATTTG</underline></bold>
###xml 934 939 934 939 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CTTAG</underline>
###xml 934 939 934 939 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>CTTAG</underline></bold>
###xml 1010 1015 1010 1015 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CAAGG</underline>
###xml 1010 1015 1010 1015 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>CAAGG</underline></bold>
###xml 1084 1090 1084 1090 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ggtacc</underline>
###xml 1101 1106 1101 1106 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ATTTG</underline>
###xml 1101 1106 1101 1106 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>ATTTG</underline></bold>
###xml 1111 1116 1111 1116 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CTTAG</underline>
###xml 1111 1116 1111 1116 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>CTTAG</underline></bold>
###xml 1139 1145 1139 1145 <underline xmlns:xlink="http://www.w3.org/1999/xlink">agatct</underline>
###xml 1155 1160 1155 1160 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CCTTG</underline>
###xml 1155 1160 1155 1160 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>CCTTG</underline></bold>
###xml 1385 1387 1385 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 2019 2021 1997 1999 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 2024 2026 2002 2004 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 2505 2508 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
A 98 bp wild-type HIF-1 binding sequence from human MCP-1 promoter region (GenBank Accession #, 2946nt 5'-AAGCAGACGTGGTACCCACAGTCTTGCTTTAACG CTACTTTTCCAAGATAAGGTGACTCAGAAAAGGACAAGGGGTGAGCCCAACCACACAGCTGCT-3' 3043nt) was PCR-amplified from genomic DNA isolated from FHAs using a pair of primers (sense primer 5'-ggggtaccATCCAAGCAGACGTGGTACC-3' and antisense primer 5'-gaagatctGAGCAGCAGCTGTGTGGTTG-3'). The bold-capital letter and underlined sequences are consensus HIF-1-binding sites, and the underlined small-letter sequences in the sense and anti-sense primers are KpnI and BglII cutting sites, respectively. The PCR fragment was cleaved with KpnI and BglII (Invitrogen) and cloned into a luciferase yellow reporter gene vector pGL3-promoter vector (Promega Madison, WI) cleaved with the same enzymes. The construct pGL3/MCP1w carrying the wild-type sequence was sequenced to confirm accuracy. A mutant sequence (5'-AAGCAGATTTGGTACCCTTAGTCTTGCTTTAACGCTACTTTTCC AAGATAAGGT GACTCAGAAA AGGACAAGGG GTGAGCCCAA CCACAAGGCTGCT-3') was generated by genomic PCR using a pair of primers (5'-ggggtacc ATCCAAGCAGATTTGGTACCCTTAGTCTTGCTTT-3', and 5'-gaagatctGAGCAGC AGCCTTGTGGTTGGGGC-3'), cleaved by KpnI and BglII and cloned into the pGL3 promoter vector. The construct pGL3/MCP1m was sequenced to confirm accuracy. The luciferase yellow reporter gene assay was performed as described previously [11]. Briefly, FHAs grown in 24-well plates to 90% confluence were transfected with 0.5 mug of either an empty pGL3 promoter vector or the vectors containing the wild-type or the mutant HIF-1-binding sequence for 2.5 hours using SuperFecttrade mark (QIAGEN, Mississauga, ON) as per manufacturer's protocol. The cells were then washed and recovered in complete media for 16 h at 37degreesC. The media were then removed, cells washed once with HBSS, and plain D-MEM was added. The cells were then exposed to hypoxia for 4 h at 37degreesC. At the end of experimental treatments, the media were removed, and cells were washed twice with Ca2+/Mg2+-free HBSS (Sigma) and then lysed in 50 mul of cell lysis reagent (Promega, Madison, WI). Reporter gene activity using luciferese assays was determined using a Promega kit. The luciferase assay reagent containing D-luciferin was added to aliquots of cell lysates and chemiluminescence was measured at 25degreesC using a chemiluminescence counter (MicroBetatrade mark TriLux, Wallac Oy, Finland). Controls for the transfection efficiency were done by simultaneous transfection of CMV beta-galactosidase (Promega, Madison, WI). The transfection efficiency was about 55% (data not shown). Total cell protein was determined in each sample using a Bradford assay (BioRad Laboratories, Hercules, CA). Light units emitted from samples were read against a standard curve (Recombinant Luciferase, Promega, Madison, WI) and normalized to protein levels in cell lysates.
###end p 31
###begin title 32
Statistical analysis
###end title 32
###begin p 33
Each assay had at least two replicates and each experiment or assay was performed at least three times and representative examples are shown. Data are reported as means +/- SD, analyzed by one-way ANOVA and p < 0.05 is considered significant.
###end p 33
###begin title 34
Results
###end title 34
###begin title 35
HIF-1-binding regions in MCP-1 and MCP-5 genes
###end title 35
###begin p 36
###xml 145 147 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 486 487 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 303 308 <span type="species:ncbi:9606">human</span>
###xml 341 346 <span type="species:ncbi:10090">mouse</span>
Our recent work demonstrated that transcriptional activation of IL-1beta in human and mouse astrocytes during hypoxia is mediated by HIF-1alpha [11]. To evaluate whether the expression of other inflammatory cytokines and chemokines would be regulated by HIF-1alpha, we analyzed genomic DNA sequences of human MCP-1 (GenBank Accession #) and mouse MCP-5 genes (GenBank Accessions # , ). Several HIF-1-binding sites were identified in the promoter regions of MCP-1 and MCP-5 genes (Table 2). The presence of HIF-1-binding sites provides the molecular basis for a hypothesis that HIF-1 regulates transcriptional activation of MCP-1 and MCP-5 expression under hypoxic conditions.
###end p 36
###begin p 37
HIF-1 binding sites in the promoter regions of MCP-1 and MCP-5 genes
###end p 37
###begin title 38
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
MCP-5 in mouse astrycotes
###end title 38
###begin p 39
###xml 133 137 125 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 150 154 138 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 193 197 177 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 244 246 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 302 306 278 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 347 351 319 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 368 369 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 465 469 429 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 483 487 443 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 503 504 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 549 553 501 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 631 635 579 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 650 651 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 717 721 657 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 790 794 726 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 846 847 782 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 919 923 847 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 999 1000 927 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1087 1089 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1129 1133 1049 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1254 1258 1166 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
To study the role of HIF-1alpha in transcriptional regulation of monocyte chemokine MCP-5, primary astrocyte cultures with HIF-1alpha+/- or HIF-1alpha+/+ genotype were generated from HIF-1alpha+/- heterozygous and wild-type mice, respectively [30]. The expression level of HIF-1alpha mRNA in HIF-1alpha+/- cells was about 50% of that in HIF-1alpha+/+ astrocytes (Fig. 1). The exposure to a-6 h hypoxia resulted in up-regulation of HIF-1alpha mRNA in both HIF-1alpha+/- and HIF-1alpha+/+ astrocytes (Fig 1). The level of HIF-1alpha mRNA in HIF-1alpha+/+ cells exposed to hypoxia increased ~50% above the level in normoxic HIF-1alpha+/+ controls (Fig. 1). However, the relative increase of HIF-1alpha mRNA in HIF-1alpha+/- cells (~140%) subjected to hypoxia was higher than that in HIF-1alpha+/+ cells (~55%) compared to its relevant control (Fig. 1). The level of HIF-1alpha mRNA expression in hypoxia-treated HIF-1alpha+/- cells was only ~20% less than that in hypoxia-treated wild-type cells (Fig. 1). Similar pattern was also observed for HIF-1alpha protein as we reported previously [11]. These results suggest that HIF-1alpha+/- cells, although having one copy of HIF-1alpha allele, responded to hypoxia at a relative higher magnitude than HIF-1alpha+/+ cells exposed to hypoxia.
###end p 39
###begin p 40
###xml 11 20 11 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 79 83 71 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 97 101 85 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 185 194 173 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Effects of in vitro hypoxia on the expression of mouse HIF-1alpha in HIF-1alpha+/- and HIF-1alpha+/+ astrocytes. Confluent astrocyte monolayers of both cell types were exposed to a 6 h in vitro hypoxia. HIF-1alpha mRNA expression was determined by RT-PCR as described in Materials and Methods. Each bar represents the mean +/- SD of relative density/volumes of the bands on film negatives from at least three experiments. Asterisks and number sign indicate significant difference (p < 0.01; one-way ANOVA, followed by multiple comparisons among means).
###end p 40
###begin p 41
###xml 88 89 88 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 157 161 153 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 217 221 209 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 233 234 225 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 317 321 305 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 335 339 319 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 405 409 385 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 456 460 432 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 472 474 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 545 549 517 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 613 617 581 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 729 733 693 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 797 801 757 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 813 815 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 941 945 897 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1000 1002 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
Both MCP-5 mRNA and protein were detected in astrocytes under normoxic conditions (Fig. 2); however, the basal levels of MCP-5 mRNA and protein in HIF-1alpha+/- astrocytes were about 50% lower than those in HIF-1alpha+/+ cells (Fig. 2). Hypoxia resulted in a significant up-regulation of MCP-5 mRNA in both HIF-1alpha+/- and HIF-1alpha+/+ astrocytes. The levels of hypoxia-induced MCP-5 mRNA in HIF-1alpha+/- cells reached the levels of normoxic HIF-1alpha+/+ cells (Fig. 2A); nevertheless, the levels of hypoxia-induced MCP-5 mRNA in HIF-1alpha+/- cells were still only 50% of those in hypoxia-treated HIF-1alpha+/+ cells. Under normaxic condition, the levels of immunoreactive MCP-5 quantified by ELISA were lower in HIF-1alpha+/- astrocyte media than those in the media obtained from HIF-1alpha+/+ cells (Fig. 2B). Hypoxia strongly stimulated the release of MCP-5 into culture media in both cell types; however, MCP-5 levels in HIF-1alpha+/- cells were only about 50% of the wild-type cells (Fig. 2B). These results suggest that the MCP-5 stimulation by hypoxia correlated with the levels of HIF-1alpha in cells.
###end p 41
###begin p 42
###xml 11 20 11 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 67 71 63 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 85 89 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 133 142 125 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Effects of in vitro hypoxia on MCP-5 expression in mouse HIF-1alpha+/- and HIF-1alpha+/+ astrocytes. The cells were exposed to a 6 h in vitro hypoxia. MCP-5 mRNA expression and immunoreactive protein secretion were determined by RT-PCR (A) and ELISA (B), respectively, as described in Materials and methods. Each bar represents the mean +/- SD of relative density/volumes of the bands on film negatives from at least three experiments or three ELISA assays. Asterisks and number signs indicate significant difference compared to relevant controls (p < 0.01; one-way ANOVA, followed by multiple comparisons among means).
###end p 42
###begin p 43
###xml 218 220 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 221 223 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 224 226 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 227 229 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 254 258 246 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 272 276 260 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 302 304 289 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 403 404 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 411 413 394 396 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 459 463 434 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 516 520 487 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 537 539 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 551 553 522 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 624 628 587 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 640 642 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 649 651 612 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 702 706 661 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 718 720 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 791 793 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 804 805 763 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 855 859 806 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 871 873 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 923 924 874 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 968 972 915 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 993 995 940 942 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1032 1033 979 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1281 1286 <span type="species:ncbi:10090">mouse</span>
The exposure to cobalt chloride or iron chelator desferoxiamine under normoxic conditions triggers transcriptional events that mimic a hypoxic condition by increasing the expression of HIF-1alpha and its target genes [12-14,26-28]. Exposure of HIF-1alpha+/- and HIF-1alpha+/+ astrocytes to 125 muM CoCl2 for 6 h induced a hypoxia-like response characterized by increased levels of HIF-1alpha mRNA (Fig. 3). CoCl2 strongly up-regulated HIF-1alpha in HIF-1alpha+/- astrocytes, reaching the levels of mRNA in HIF-1alpha+/+ astrocytes (Fig. 3A). Both CoCl2 and hypoxia up-regulated the levels of HIF-1alpha protein in HIF-1alpha+/- cells (Fig. 3B). CoCl2 significantly up-regulated MCP-5 mRNA in HIF-1alpha+/- cells (Fig. 4A) and the release of immunoreactive MCP-5 protein from the cells (Fig. 4B). The CoCl2-induced up-regulation of HIF-1alpha in HIF-1alpha+/+ cells (Fig. 3A) was less potent than that induced hypoxia (Fig. 1). Therefore, MCP-5 expression in HIF-1alpha+/+ cells exposed to CoCl2 was not significantly affected (Fig. 4). The presence of HIF-1-binding sites in the promoter of MCP-5 gene and the observation that the expression of MCP-5 correlated with the levels of HIF-1alpha suggest that HIF-1alpha is involved in transcriptional regulation of MCP-5 expression in mouse astrocytes.
###end p 43
###begin p 44
###xml 15 17 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 74 75 70 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 144 146 139 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 498 499 487 488 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 573 575 562 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 625 629 606 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 643 647 620 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Effects of CoCl2 treatment on HIF-1alpha expression in mouse astrocytes. (A) The cells were incubated in the presence or absence of 125 muM CoCl2 for 6 hr. HIF-1alpha mRNA expression was determined by RT-PCR. Each bar represents the mean +/- SD of relative density/volumes of the bands on film negatives from at least three experiments. Asterisk and number sign indicate significant difference compared to relevant controls (p < 0.01; one-way ANOVA, followed by multiple comparisons among means). (B) Western blots using nuclear proteins show that both hypoxia (H) and CoCl2 (Co) up-regulated HIF-1alpha protein in HIF-1alpha+/+ and HIF-1alpha+/- cells. There was no HIF-1alpha protein detected in control cells (C).
###end p 44
###begin p 45
###xml 15 17 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 66 70 62 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 84 88 76 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 167 169 158 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Effects of CoCl2 treatment on MCP-5 expression in mouse HIF-1alpha+/- and HIF-1alpha+/+ astrocytes. The cells were incubated in the presence or absence of 125 muM CoCl2 for 6 hr. MCP-5 expression at the mRNA and protein levels was determined by RT-PCR (A) and ELISA (B), respectively. Each bar represents the mean +/- SD of relative density/volumes of the bands on film negatives from least three experiments or three ELISA assays. Asterisks and number signs indicate significant difference compared to relevant controls (p < 0.01; one-way ANOVA, followed by multiple comparisons among means).
###end p 45
###begin title 46
###xml 15 20 <span type="species:ncbi:9606">human</span>
MCP-1 in fetal human astrocytes (FHAs)
###end title 46
###begin p 47
###xml 152 154 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 284 286 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 382 383 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 520 522 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
As shown previously, HIF-alpha was strongly up-regulated in FHAs at both mRNA and protein levels in response to 4 h hypoxia or 125 muM cobalt chloride [11]. Both hypoxia and cobalt chloride also strongly up-regulated the expression of MCP-1 mRNA in FHAs as compared to controls (Fig. 5A). The level of immunoreactive MCP-1 released by hypoxia-treated (14015 +/- 2770 pg/ml) and CoCl2-treated FHAs (15702.09 +/- 1137.85) was about two-fold higher than that secreted by control FHAs (7092 +/- 1920 pg/ml) (p < 0.05) (Fig. 5B).
###end p 47
###begin p 48
###xml 26 28 26 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 183 185 182 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 67 72 <span type="species:ncbi:9606">human</span>
Effects of hypoxia or CoCl2 treatment on MCP-1 expression in fetal human astrocytes (FHAs). MCP-1 mRNA expression and immunoreactive protein in FHAs exposed to hypoxia or 125 muM CoCl2 for 4 h were determined by RT-PCR (A) and ELISA (B), respectively, as described in Materials and methods. Panel A shows that four dishes of cells were used per treatment, and four RT-PCR reactions per treatment were therefore carried out. Each bar represents the mean +/- SD of relative density/volumes of the bands on film negatives from least three experiments or three ELISA assays. Asterisks indicate significant difference compared to relevant controls (one-way ANOVA, followed by multiple comparisons among means; p < 0.01 for Panel A, p < 0.05 for Panel B).
###end p 48
###begin title 49
HIF-1 interacts with HIF-1-binding DNA sequence
###end title 49
###begin p 50
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 506 510 502 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 554 558 546 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 585 587 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 676 678 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 846 848 834 836 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 355 360 <span type="species:ncbi:10090">mouse</span>
Since HIF-1-binding sequences are identified in the promoter regions of MCP-1 and MCP-5 genes (Table 2), the binding of HIF-1 protein complex to a typical HIF-1-binding consensus DNA sequence [15,16] was examined by EMSA as described in the Materials and methods. HIF-1 protein complex in nuclear extracts prepared from hypoxia-or cobalt chloride-treated mouse astrocytes was capable of binding the wild-type DNA sequence but not the mutant sequence (Fig. 6A). More HIF-1/DNA complex was seen in HIF-1alpha+/+ cells (lanes #2 & 3) than that in HIF-1alpha+/- cells (lanes #5 & 6) (Fig. 6A). The HIF-1/DNA complex was up-shifted in the presence of the HIF-1alpha antibody (Fig. 6A). The EMSA and supershift assay results provide the evidence that HIF-1 physically interacts with the consensus HIF-1-binding sequence under hypoxic conditions or CoCl2 treatment.
###end p 50
###begin p 51
###xml 26 28 26 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 102 103 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 121 125 117 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 139 143 131 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 188 190 179 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 358 359 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 512 514 503 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 651 652 642 643 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 671 675 658 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 723 724 710 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 743 747 726 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 929 930 907 908 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 105 110 <span type="species:ncbi:10090">Mouse</span>
Effects of hypoxia or CoCl2 treatment on HIF-1 DNA binding and reporter gene activity in astrocytes. (A) Mouse HIF-1alpha+/+ and HIF-1alpha+/- cells were exposed to hypoxia or 125 muM CoCl2 for 6 h, nuclear extracts were then prepared and EMSA carried out as described in the Materials and Methods. HIF-1 in the nuclear extracts isolated from hypoxia or CoCl2-treated cells bound to the wild-type probe (lanes #1-6) but not to the mutant probe (lanes #7-12). HIF-1/DNA complex was detected in hypoxia (H)-or CoCl2 (Co)-treated cells (lanes #2, 3, 5, 6) but not in control (C) cells (lanes #1, 4). More complex (darker band) was seen in hypoxia-or CoCl2-treated HIF-1alpha+/+ cells (lanes #2, 3) than that in hypoxia-or CoCl2-treated HIF-1alpha+/- cells (lanes #5, 6). Supershift assay showed that the HIF-1/DNA complex was shifted up in the presence of wild-type (wt) oligo probe and 4 mug HIF-1alpha antiboby (lanes #13 & 14). (B) The activity of the reporter gene, luciferase yellow, under a wild-type HIF-1-binding sequence from MCP-1 promoter (pGL3/MCP1w) or a mutated sequence (pGL3/MCP1m), was carried out to test the transcriptional activation of MCP-1 by HIF-1 activated by hypoxia. FHAs were transfected with an empty vector, pGL3/MCP1w or pGL3/MCP1m, respectively, and recovered overnight for 16 h. The cells were exposed to normoxia or hypoxia for 4 h and then harvested for luciferase yellow assays. Hypoxia strongly stimulated the reporter gene activity from pGL3/MCP1w but not from the empty vector and pGL3/MCP1m. Each bar represents the mean +/- SD of three assays and each assay had at least two replicates. Asterisks indicate significant difference compared to relevant controls (p < 0.05, one-way ANOVA, followed by multiple comparisons among means).
###end p 51
###begin p 52
###xml 496 498 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 671 673 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
To further demonstrate the interaction of HIF-1alpha with HIF-1-binding DNA sequence, the HIF-1-binding sequence from the promoter region of MCP-1 gene or a mutant sequence was cloned into a luciferase reporter gene vector. The constructs were transfected into FHAs cells, which were then subjected to normoxia or hypoxia for 4 h. The luciferease activity from the cells transfected with either an empty or mutant vector did not show significant change under normoxic or hypoxic conditions (Fig. 6B). However, the luciferase reporter activity from the cells transfected with pGL3/MCP1w was significantly increased during hypoxia (p < 0.05) compared to the controls (Fig. 6B). The reporter gene assay results demonstrate that HIF-1 interacts with the HIF-1-binding sequence in MCP-1 gene and activates MCP-1 transcription in FHAs exposed to hypoxia.
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 470 472 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 473 475 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 476 478 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 813 814 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 815 816 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1182 1184 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1185 1187 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1273 1275 1258 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1276 1278 1261 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1281 1289 1266 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 1492 1494 1477 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1495 1497 1480 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1498 1500 1483 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1501 1503 1486 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1728 1730 1713 1715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1802 1804 1787 1789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1805 1807 1790 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1954 1956 1939 1941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1957 1959 1942 1944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1967 1976 1952 1961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1980 1988 1965 1973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1486 1490 <span type="species:ncbi:10090">mice</span>
###xml 1722 1726 <span type="species:ncbi:10116">rats</span>
The data presented above suggest that both MCP-1 and MCP-5 are HIF-1 target genes. This is illustrated by the presence of HIF-1-binding sites in their promoter regions, the up-regulation by hypoxia and cobalt chloride, and the general correlative relationship between HIF-1alpha and the levels of MCP-1 and MCP-5 in astrocytes. Up-regulation of MCP-1 and MCP-5 by HIF-1alpha in astrocytes exposed to hypoxia, similar to that observed for IL-1beta, EPO, VEGF and others [11-14,20], is likely an adaptive response to hypoxic environment; however, HIF-1alpha-mediated up-regulation of inflammatory mediators also initiates an inflammatory process. Infiltration of peripheral inflammatory cells into the brain is a critical step in the development and progression of the neuroinflammation evoked by hypoxia/ischemia [1-3]. Chomokines (including MCP-1, MCP-5, IL-8, GRO, etc) produced by astrocytes and other cell types in response to hypoxia/ischemia play a central role in the inflammatory process by forming a chemoattractant gradient that attracts blood-borne inflammatory cells (neutrophils, monocytes and macrophages) to transmigrate across the blood-brain barrier into the brain [32-39]. Both MCP1 and MCP-5 are potent chemokines selective for monocytes and macrophages [29,32]. In vivo studies have shown that infiltrating blood-borne monocytes and macrophages were recruited into the ischemic tissue as early as 18 h following a transient middle cerebral artery occlusion (MCAO) in mice [32,35,36,39]. The infiltration peaked at 48 h and remained abundant at 96 h after MCAO. Furthermore, anti-MCP-1 gene therapy attenuated infarct volume and infiltration of inflammatory cells in focal brain ischemia of hypertensive rats [38]. Astrocytes are main cytokine/chemokine-producing cells in the brain [34,37], and astrocyte-produced MCP-1 directs the transmigration of monocytes and macrophages across the BBB to the sites of axonal injury in the brain [33,37]. Both in vitro and in vivo findings suggest that hypoxia/ischemia-induced infiltration of monocytes and macrophages contributes to the pathophysiology and damage induced by stroke.
###end p 54
###begin p 55
###xml 186 187 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 188 189 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 190 192 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 193 195 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 256 258 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 494 495 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 496 498 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1052 1053 1044 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1054 1055 1046 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1056 1058 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1147 1156 1139 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1185 1187 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1625 1634 1613 1622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1680 1688 1668 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1709 1718 1697 1706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1722 1730 1710 1718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1804 1812 1792 1800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1847 1856 1835 1844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1105 1108 <span type="species:ncbi:10116">rat</span>
Up-regulation of inflammatory genes by hypoxia/ischemia may be regulated by different transcription factors at different stages of the inflammation, including HIF-1, NFkappaB, and AP-1 [3,8,10,40]. The evidence provided in this study and an previous work [11] established that HIF-1 induces transcriptional up-regulation of inflammatory cytokines and chemokines during hypoxia; whereas NFkappaB is mainly involved in transcriptional regulation of these genes during the phase of reoxygenation [8,40]. The temporal interplay of these transcription factors may be critical in the regulation of inflammatory gene expression at different stages of hypoxia/ischemia-evoked inflammation. Targeting transcriptional regulators of inflammatory genes may help tune the inflammatory response. Neuroinflammation following brain ischemic damage is an important part of damage resolution process by which macrophages remove dead cells and inflammatory mediators stimulate multipotent cells to differentiate to functional neuronal or glial cells in the injured area [1-3,42]. MCP-1 has been shown to induce migration of rat-derived adult neural stem cells in an in vitro model of brain inflammation [43]. Tuning of MCP-1 levels at different stages of the inflammation associated with ischemic brain damage may maximize the benefit effects of the inflammation. The evidence of HIF-1alpha-mediated up-regulation of MCP-1 and MCP-5 during hypoxia suggests that HIF-1 may be a target for the regulation of inflammatory chemokines in the neuroinflammation induced by hypoxia/ischemia. However, it should be noted that the observations from this in vitro study may not be entirely extrapolated to the in vivo situations since the in vitro and in vivo responses of astrocytes to hypoxia/ischemia may not be identical. Further in vivo studies are needed to validate the in vitro observations.
###end p 55
###begin title 56
Conclusion
###end title 56
###begin p 57
###xml 112 114 112 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 266 268 262 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 331 336 <span type="species:ncbi:10090">mouse</span>
This study has identified HIF-1-binding sites in the promoter regions of MCP-1 and MCP-5 genes. Hypoxia and CoCl2 up-regulate the expression of both HIF-1alpha and chemokines MCP-1 and MCP-5 in astrocytes. The levels of MCP-5 up-regulation induced by hypoxia or CoCl2 correlated with the levels of hypoxia-stimulated HIF-1alpha in mouse astrocytes. HIF-1 protein complex activated by hypoxia binds to the HIF-1-binding DNA sequence as shown by EMSA and activates MCP-1 transcription as demonstrated by reporter gene assay, respectively. These findings suggest that HIF-1 is involved in transcriptional regulation of hypoxia-upregulated expression of chemokines MCP-1 and MCP-5 in astrocytes.
###end p 57
###begin title 58
Abbreviations
###end title 58
###begin p 59
AP-1: Activator protein-1
###end p 59
###begin p 60
BBB: Blood-brain barrier
###end p 60
###begin p 61
###xml 37 42 <span type="species:ncbi:9606">human</span>
CCL2: Chemokine, CC motif, ligand 2 (human MCP-1)
###end p 61
###begin p 62
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Ccl12: Chemokine, CC motif, ligand 12 (mouse MCP-5)
###end p 62
###begin p 63
ELISA: Enzyme-linked immunosorbent assay
###end p 63
###begin p 64
EMSA: Electrophoretic mobility shift assay
###end p 64
###begin p 65
EPO: Erythropoetin
###end p 65
###begin p 66
HIF-1: Hypoxia-inducible factor-1
###end p 66
###begin p 67
ICAM-1: Intercellular adhesion molecule-1
###end p 67
###begin p 68
IL-1beta: Interleukin-1beta
###end p 68
###begin p 69
IL-8: Interleukin-8
###end p 69
###begin p 70
MCAO: Middle cerebral artery occlusion
###end p 70
###begin p 71
MCP-1: Monocyte chemoattractant protein-1 or CCL2
###end p 71
###begin p 72
MCP-5: Monocyte chemoattractant protein-5 or Ccl12
###end p 72
###begin p 73
NFkappaB: Nuclear factor kappa B
###end p 73
###begin p 74
PCR: Polymerase chain reaction
###end p 74
###begin p 75
RT: Reverse transcription
###end p 75
###begin p 76
TNF-alpha: Tumor necrosis factor-alpha
###end p 76
###begin p 77
VEGF: Vascular endothelial growth factor
###end p 77
###begin title 78
Competing interests
###end title 78
###begin p 79
The author(s) declare that they have no competing interests.
###end p 79
###begin title 80
Authors' contributions
###end title 80
###begin p 81
###xml 75 79 71 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 93 97 85 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 364 368 352 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
JMP performed the experiments on mouse astrocytes generated from HIF-1alpha+/- and HIF-1alpha+/+ mice (genotyping, RT-PCR and ELISA) and reviewed the manuscript. DC performed western blots, EMSA and supershift assays. HC conducted experiments on FHAs (RT-PCR and ELISA). CD performed EMSA and reporter gene assays. DS conceived the experiments, obtained HIF-1alpha+/- mice, prepared the figures, and revised the manuscript. WZ conceived the experiments, performed sequence analysis for HIF-1 binding sites, designed the primers and oligos, cloned HIF-1 binding sequence from MCP-1 gene into reporter gene vector, oversaw the project, prepared the figures and wrote/revised the manuscript.
###end p 81
###begin title 82
Acknowledgements
###end title 82
###begin p 83
###xml 103 107 99 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 265 270 <span type="species:ncbi:10090">mouse</span>
The authors thank Dr. Peter Carmeliet at the University of Leuven, Belgium for providing the HIF-1alpha+/- mice and the workers in the Animal Facility at the NRC-Institute for Biological Sciences. The authors appreciate the help of Ms. Aimee Jones with some of the mouse astrocyte cultures. This work was supported by a research grant (#T5099) from the Heart & Stroke Foundation of Canada to DS and WZ.
###end p 83
###begin article-title 84
The role of cytokines in the neuropathology of stroke and neurotrauma
###end article-title 84
###begin article-title 85
Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation
###end article-title 85
###begin article-title 86
Current and future therapeutic strategies to target inflammation in stroke
###end article-title 86
###begin article-title 87
Interleukin 1 in the brain: biology, pathology and therapeutic target
###end article-title 87
###begin article-title 88
###xml 27 32 <span type="species:ncbi:9606">human</span>
The induction of ICAM-1 in human cerebromicrovascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/HCEC adhesion
###end article-title 88
###begin article-title 89
###xml 47 52 <span type="species:ncbi:9606">human</span>
Increase expression of bioactive chemokines in human cerebromicrovascular endothelial cells and astrocytes subjected to simulated ischemia in vitro
###end article-title 89
###begin article-title 90
###xml 27 32 <span type="species:ncbi:9606">human</span>
Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1beta
###end article-title 90
###begin article-title 91
###xml 35 40 <span type="species:ncbi:9606">human</span>
Inflammatory gene transcription in human astrocytes exposed to hypoxia: roles of the nuclear factor-kappaB and autocrine stimulation
###end article-title 91
###begin article-title 92
###xml 104 109 <span type="species:ncbi:9606">human</span>
Indomethacin and cyclosporin A inhibit in vitro ischemia-induced expression of ICAM-1 and chemokines in human brain endothelial cells
###end article-title 92
###begin article-title 93
###xml 114 119 <span type="species:ncbi:9606">human</span>
A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells
###end article-title 93
###begin article-title 94
Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of Interleukin-1beta (IL-1beta) in astrocyte cultures
###end article-title 94
###begin article-title 95
Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis
###end article-title 95
###begin article-title 96
Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1
###end article-title 96
###begin article-title 97
Hydroxylation of HIF-1: oxygen sensing at molecular level
###end article-title 97
###begin article-title 98
Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia
###end article-title 98
###begin article-title 99
Purification and characterization of hypoxia-inducible factor 1
###end article-title 99
###begin article-title 100
Molecular characterization and chromosomal localization of third alpha-class hypoxia inducible subunit, HIF-3alpha
###end article-title 100
###begin article-title 101
Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha: Modulation of transcriptional activity by oxygen tension
###end article-title 101
###begin article-title 102
Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression
###end article-title 102
###begin article-title 103
Mammalian oxygen sensing, signalling and gene regulation
###end article-title 103
###begin article-title 104
Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway
###end article-title 104
###begin article-title 105
Hypoxia-Inducible Factor-1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin proteasome system under normoxic conditions
###end article-title 105
###begin article-title 106
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
###end article-title 106
###begin article-title 107
In vivo expression of mRNAs encoding hypoxia-inducible factor 1
###end article-title 107
###begin article-title 108
###xml 79 84 <span type="species:ncbi:9606">human</span>
A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
###end article-title 108
###begin article-title 109
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1
###end article-title 109
###begin article-title 110
###xml 94 97 <span type="species:ncbi:9615">dog</span>
Effects of testosterone, cobalt and hypoxia on erythropoietin production in isolated perfused dog kidney
###end article-title 110
###begin article-title 111
Combined effect of cobalt and testosterone on erythropoiesis
###end article-title 111
###begin article-title 112
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 119 124 <span type="species:ncbi:9606">human</span>
Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1
###end article-title 112
###begin article-title 113
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
###end article-title 113
###begin article-title 114
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Differential proliferative responses of human and mouse astrocytes to gamma interferon
###end article-title 114
###begin article-title 115
Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells
###end article-title 115
###begin article-title 116
###xml 116 121 <span type="species:ncbi:9606">human</span>
Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier
###end article-title 116
###begin article-title 117
Monocyte:astrocyte interactions regulate MCP-1 expression in both cell types
###end article-title 117
###begin article-title 118
###xml 41 44 <span type="species:ncbi:10116">rat</span>
CD8+ phagocytes in focal ischemia of the rat brain: predominant origin from hematogenous macrophages and targeting to areas of pannecrosis
###end article-title 118
###begin article-title 119
###xml 114 118 <span type="species:ncbi:10090">mice</span>
The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice
###end article-title 119
###begin article-title 120
Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS
###end article-title 120
###begin article-title 121
###xml 107 111 <span type="species:ncbi:10116">rats</span>
Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats
###end article-title 121
###begin article-title 122
###xml 210 214 <span type="species:ncbi:10090">mice</span>
Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: an investigation using green fluorescent protein transgenic bone marrow chimeric mice
###end article-title 122
###begin article-title 123
Inflammatory activation of brain cells by hypoxia: transcription factors and signaling pathways
###end article-title 123
###begin article-title 124
###xml 62 67 <span type="species:ncbi:9606">human</span>
Effects of hypoxia on inflammatory gene expression in primary human fetal astrocytes
###end article-title 124
###begin article-title 125
Expression of MCP-1 in the Hippocampus of SHRSP with Ischemia-Related Delayed Neuronal Death
###end article-title 125
###begin article-title 126
MCP-1 induces migration of adult neural stem cells
###end article-title 126

